Oramed Pharmaceuticals Inc

ORMPNASDAQ · USD
4.74USD0.00 (+1.50%)
8110

Oramed Pharmaceuticals Inc (ORMP) Implied Volatility Current

ORMP implied volatility is 115%. IV Rank is 23%, placing current premiums in the bottom of their 52-week range.

Read more

Tracking ORMP implied volatility helps you identify when options premiums on Oramed Pharmaceuticals Inc are historically cheap or expensive, and where the best trades are hiding. Oramed Pharmaceuticals Inc implied volatility reflects the market's expectation of future price movement: when ORMP IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Oramed Pharmaceuticals Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ORMP, tracking metrics like ORMP IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ORMP signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule.

The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ORMP implied volatility sits today versus where it has been. Our scanner ranks Oramed Pharmaceuticals Inc implied volatility against its historical range, surfaces extremes in ORMP IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Oramed Pharmaceuticals Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
23.41%IV Rank
Low

IV is compressed vs the past year - options are relatively cheap, favoring buyers.

Implied Volatility (30d)115.40%

IV Rank23.41%

Historical Volatility (30d)41.49%

IV - HV+73.91%

As of September 18, 2026

Trade options with IV on your side

Track ORMP IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial